NanoBio® Corporation is a privately-held biopharmaceutical company focused on developing and commercializing novel products for the prevention and treatment of infectious diseases, based on its patented NanoStatÔ technology platform. Founded in 2000 as a spin-out from the Center for... more

ImQuest BioSciences strives to provide research and development services to the highest scientific standards and expects that data provided by the laboratories will be suitable for publication in peer reviewed journals, in Investigational New Drug applications with the FDA, as components... more

Neosil, Inc. is a privately held dermatology-focused pharmaceutical company that was funded in November 2004 with a $32 million investment by MPM Capital and Burrill & Company, following initial incubation funding by Shalon Ventures, LP. In addition to Dr. Bauer and Dr. Mundy, Neosil's... more